Anti-Allergy Drug Need Associated With use of Gastric Suppression Agents
People who take gastric acid suppression agents have a high risk of requiring subsequent anti-allergy drugs.
All articles by Brandon May
Dupilumab Improves QoL in Uncontrolled Asthma and Allergic Rhinitis
Dupilumab is generally well tolerated and improves health-related quality of life associated with rhinoconjunctivitis in patients with uncontrolled moderate to severe asthma with comorbid allergic rhinitis.
Improving FEV1 in Children With Asthma: Tiotropium Add-On to ICS vs LTRAs
Tiotropium may be superior to leukotriene receptor antagonists (LTRAs) as an add-on therapy to an inhaled corticosteroid (ICS) for improving forced expiratory volume (FEV1) in children and adolescents with asthma.
Mepolizumab Improves QoL in Comorbid Asthma and Upper Airway Disease
Mepolizumab was associated with improvements in asthma control and quality of life, as well as reductions in disease exacerbations in patients with comorbid severe asthma and upper airway disease.
GSP301 Improves Ocular Symptoms in Seasonal Allergic Rhinitis
Twice daily GSP301, a fixed-dose nasal spray containing 665µg olopatadine hydrochloride and 25µg mometasone furoate, offers a rapid onset of action, is well tolerated, and is associated with noticeable improvements in ocular symptoms in patients with seasonal allergic rhinitis.
ACIP Updates Recommendations for US Adult Immunization Schedule
The ACIP and CDC have approved and released 2019 recommendations for the adult immunization schedule in the US.
Upadacitinib Improves Pruritus in Moderate to Severe Atopic Dermatitis
Upadacitinib, a selective janus kinase-1 inhibitor, was associated with early improvements in pruritus in patients with moderate to severe atopic dermatitis.
Can Beclomethasone Dipropionate Aid Lung Function in Persistent Asthma?
Significant improvements were seen in lung function in patients who received either dose of beclomethasone dipropionate.
Reslizumab Improves Sleep Quality in Inadequately Controlled Asthma
Patients who received reslizumab experienced significantly greater improvements in each sleep-related related Asthma Quality of Life Questionnaire question score compared with placebo.
Eosinophilic Esophagitis Symptoms Reduced With Anti-Interleukin 13 Antibody
Significantly greater reductions in the mean esophageal eosinophil counts occurred in patients who received the humanized anti-interleukin 13 antibody, RPC4046.
